Endometrial carcinoma (EC) harboring POLE exonuclease domain mutations occurs in 5-15% of ECs and frequently affects young women with low body mass index (BMI). It presents at early stage as high grade endometrioid histotype with intense tumor infiltrating lymphocytes and has good clinical outcomes and favorable prognosis. In this article we report the case of a 32-year-old woman with endometriod EC (EEC) exhibiting a "ultramutated" molecular profile and an excellent prognosis despite tumor size and grading. Herein, to highlight the importance of defining POLE status in ECs for both clinical and therapeutic implications for patients.
POLE exonuclease domain mutations in endometrial carcinoma: a case report
Pasciuto, Maria Paola;Zampacorta, Claudia;Ferro, Benedetta;Di Marino, Pietro;Primavera, Francesca Chiara;Rossetti, Rebecca;Marchetti, Antonio;Buttitta, Fiamma;D'Angelo, Emanuela
2023-01-01
Abstract
Endometrial carcinoma (EC) harboring POLE exonuclease domain mutations occurs in 5-15% of ECs and frequently affects young women with low body mass index (BMI). It presents at early stage as high grade endometrioid histotype with intense tumor infiltrating lymphocytes and has good clinical outcomes and favorable prognosis. In this article we report the case of a 32-year-old woman with endometriod EC (EEC) exhibiting a "ultramutated" molecular profile and an excellent prognosis despite tumor size and grading. Herein, to highlight the importance of defining POLE status in ECs for both clinical and therapeutic implications for patients.| File | Dimensione | Formato | |
|---|---|---|---|
|
872-Article Text-8250-1-10-20230522.pdf
accesso aperto
Dimensione
284.01 kB
Formato
Adobe PDF
|
284.01 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
